The Valley Desk

NCT03845166 · Interventional trial

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Overall registry status Active not recruiting

Phase 1

Conditions Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant, Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov